IP Library Granted Patent US 7,733,009
Granted Patent B2
US 7,733,009 · App. 11/412,426 · Granted Jun 8, 2010

Electroluminescent device including an anthracene derivative

Assignee: Global OLED Technology LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,733,009
App. No.
11/412,426
Granted
Jun 8, 2010
Kind
B2
Abstract

An electroluminescent device comprises a cathode, an anode, and has therebetween a light emitting layer (LEL), the device further containing an electron transport layer (ETL) on the cathode side of the LEL and an organic electron injection layer (EIL) contiguous to the ETL on the cathode side, wherein the ETL contains a monoanthracene compound bearing aromatic groups in the 2-, 9-, and 10-positions.

Claims (15)

1. An electroluminescent device comprising:

a cathode,

an anode, and

having therebetween a light emitting layer (LEL) including an anthracene material bearing aryl groups comprising no more than two fused rings in each of the 2-, 9-, and 10-positions and a light-emitting material comprising boron or a light-emitting material comprising a styrylarene derivative;

the device further comprising an electron transport layer (ETL) on the cathode side of the LEL and an organic electron injection layer (EIL) contiguous to the ETL on the cathode side,

wherein the ETL contains a monoanthracene compound that is substituted with a naphthyl or a biphenyl group in the 9-position, an independently selected naphthyl or a biphenyl group in the 10-position, and an aryl group comprising no more than two fused rings in the 2-position; and

wherein the EIL includes an organic heterocyclic compound selected from a derivative of 1,10-phenanthroline, a derivative of benzimidazole, and a 2,2′-bipyridyl derivative.

2. The device of claim 1 wherein the difference in LUMO values between the monoanthracene compound and the heterocyclic compound is 0.2 eV or less.

3. The device of claim 2 wherein the electron injection layer includes a heterocyclic compound that has a LUMO value equal to or more positive than the LUMO value of the monoanthracene compound.

4. The device of claim 1 wherein the thickness of the electron injection layer is 1 to 20 nm.

5. The device of claim 1 wherein the thickness of the electron injection layer is greater than 10 nm but less than 20 nm.

6. The device of claim 1 wherein the thickness of the electron injection layer is greater than 20 nm.

7. The device of claim 1 wherein the electron injection layer comprises a derivative of 1,10-phenanthroline bearing at least one substituent comprising at least three fused aromatic rings.

8. The device of claim 1 wherein the electron injection layer comprises 4,7-diphenyl-1,10-phenanthroline or 2,2′,2″-(1,3,5-benzenetriyl)tris[1-phenyl-1H-benzimidazole].

9. The device of claim 1 wherein the LEL emits blue, blue-green, or green light.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2010
From: EASTMAN KODAK COMPANY
To: GLOBAL OLED TECHNOLOGY LLC
Reel/Frame 024068/0468 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2006
From: KONDAKOV, DENIS; CONLEY, SCOTT R.; KLUBEK, KEVIN P.; VARGAS, J. RAMON
To: EASTMAN KODAK COMPANY
Reel/Frame 017834/0218 →
Continuity (1)
Related Publication 20070252521A1 · Nov 1, 2007